Halozyme Therapeutics Inc (NASDAQ:HALO)

Delayed Data
As of Apr 24
 -0.085 / -0.50%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Halozyme Therapeutics Inc have a median target of 19.50, with a high estimate of 26.00 and a low estimate of 5.00. The median estimate represents a +15.66% increase from the last price of 16.86.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Halozyme Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 08

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -232.33%
Growthannually 10.25%


Growthquarterly -36.13%
Growthannually 23.85%
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account